Anixa Biosciences Announces First Chinese Patent on its CAR-T Cancer Therapy Technology October 6, 2021
Anixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy October 1, 2021
Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposium September 14, 2021
Anixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 8, 2021
Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer CAR-T Immunotherapy August 30, 2021
Anixa Biosciences' Covid-19 Compounds Expected to be Effective Against the Delta Variant August 25, 2021
Anixa Biosciences Congratulates Director, Dr. Arnold Baskies for His Appointment to the WHO's Global Breast Cancer Initiative August 23, 2021
Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology August 18, 2021
Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic May 26, 2021